PBT2 in Huntington Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

被引:0
|
作者
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
S451 WIP
引用
收藏
页码:S51 / S52
页数:2
相关论文
共 50 条
  • [31] A randomized, double-blind, placebo-controlled study of tetrabenazine in patients with Huntington's disease.
    Marshall, FJ
    MOVEMENT DISORDERS, 2004, 19 (09) : 1122 - 1122
  • [32] A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease
    Kieburtz, Karl
    Landwehrmeyer, Georg B.
    Cudkowicz, Merit
    Dorsey, E. Ray
    Feigin, Andrew
    Hunt, Victoria
    Kayson, Elise
    McDermott, Michael
    Noonberg, Sarah
    Seitz, Wendy
    Soliveri, Paola
    Walker, Francis
    Burgunder, Jean-Marc
    Romero, Irene
    Magara, Anouk
    Stebler, Yanik
    Rickards, Hugh
    Wright, Jan
    De Souza, Jenny
    Barker, Roger A.
    Mason, Sarah
    Di Pietro, Anna
    Goodman, Anna
    O'Keeffe, Deidre
    Langlois, Melanie
    Ferland, Germain
    Verret, Louis
    Chouinard, Sylvain
    Paris, Suzanne
    LePage, Christiane
    Nemeth, Andrea H.
    Merritt, Claire
    Cox, Caroline
    Astbury, Therese
    Murphy, Sarah
    Ahmed, Anwar
    St Marie, Patricia
    Berila, Rose Anne
    Kubu, Cynthia
    Segro, Vicki
    Kumar, Rajeev
    Erickson, Diane
    Schneiders, Jay
    Frucht, Steven
    Wasserman, Paula
    Moskowitz, Carol
    Scott, Burton
    Perry-Trice, Peggy
    Wyne, Sarah
    Soliveri, Paola
    JAMA NEUROLOGY, 2013, 70 (01) : 25 - 33
  • [34] Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease
    Grill, Joshua D.
    Tam, Steven
    Thai, Gaby
    Vides, Beatriz
    Pierce, Aimee L.
    Green, Kim
    Gillen, Daniel L.
    Teng, Edmond
    Kremen, Sarah
    Beigi, Maryam
    Rissman, Robert A.
    Leger, Gabriel C.
    Balasubramanian, Archana
    Revta, Carolyn
    Morrison, Rosemary
    Jennings, Robin
    Pa, Judy
    Zhang, Jing
    Jin, Shelia
    Messer, Karen
    Feldman, Howard H.
    NEUROLOGY, 2025, 104 (01)
  • [35] Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
    Holubar, Marisa
    Subramanian, Aruna
    Purington, Natasha
    Hedlin, Haley
    Bunning, Bryan
    Walter, Katharine S.
    Bonilla, Hector
    Boumis, Athanasia
    Chen, Michael
    Clinton, Kimberly
    Dewhurst, Liisa
    Epstein, Carol
    Jagannathan, Prasanna
    Kaszynski, Richard H.
    Panu, Lori
    Parsonnet, Julie
    Ponder, Elizabeth L.
    Quintero, Orlando
    Sefton, Elizabeth
    Singh, Upinder
    Soberanis, Luke
    Truong, Henry
    Andrews, Jason R.
    Desai, Manisha
    Khosla, Chaitan
    Maldonado, Yvonne
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (11) : 1883 - 1892
  • [36] Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial
    Moussa, Charbel
    ANNALS OF NEUROLOGY, 2020, 88 : S100 - S100
  • [37] Onset of Migraine Preventive Effects With Rimegepant in a Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Trial
    Lipton, R. B.
    Kudrow, D.
    Smith, T.
    Croop, R.
    Jensen, C. M.
    Kamen, L.
    Thiry, A.
    Coric, V.
    Goadsby, P. J.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 27 - 28
  • [38] A Phase 2 Randomized, Double-blind, Placebo-controlled Trial of PRAX-944 for the Treatment of Essential Tremor
    Olhaye, O.
    Belfort, G.
    Raines, S.
    Snyder, T.
    Ravina, B.
    MOVEMENT DISORDERS, 2022, 37 : S427 - S427
  • [39] Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial
    Pignolo, Robert J.
    Baujat, Genevieve
    Hsiao, Edward C.
    Keen, Richard
    Wilson, Amy
    Packman, Jeff
    Strahs, Andrew L.
    Grogan, Donna R.
    Kaplan, Frederick S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 (10) : 1891 - 1902
  • [40] Onset of Migraine Preventive Effects With Rimegepant in a Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Trial
    Lipton, R. B.
    Kudrow, D.
    Smith, T.
    Croop, R.
    Jensen, C. M.
    Kamen, L.
    Thiry, A.
    Coric, V.
    Goadsby, P. J.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 18 - 19